Transmission-Dependent Tolerance to Multiclonal Plasmodium falciparum Infection

Färnert, Anna; Williams, Thomas N.; Mwangi, Tabitha W.; Ehlin, Anna; Fegan, Greg; Macharia, Alex; Lowe, Brett S.; Montgomery, Scott M.; Marsh, Kevin
October 2009
Journal of Infectious Diseases;10/1/2009, Vol. 200 Issue 7, p1166
Academic Journal
Whether the number of concurrent clones in asymptomatic Plasmodium falciparum infections reflects the degree of host protection was investigated in children living in areas with different levels of transmission on the coast of Kenya. The number of concurrent clones was determined on the basis of polymorphism in msp2, which encodes the vaccine candidate antigen merozoite surface protein 2. In a low-transmission area, most children had monoclonal infections, and diversity did not predict a risk of clinical malaria. In an area of moderate transmission, asymptomatic infections with 2 clones were, compared with 1 clone, associated with an increased risk of subsequent malaria. In a comparative assessment in a high-transmission area in Tanzania, multiclonal infections conferred a reduced risk. The different nonlinear associations between the number of clones and malaria morbidity suggest that levels of tolerance to multiclonal infections are transmission dependent as a result of cumulative exposure to antigenically diverse P. falciparum infections.


Related Articles

  • Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial. Aide, Pedro; Aponte, John J.; Renom, Montse; Nhampossa, Tacilta; Sacarlal, Jahit; Mandomando, Inacio; Bassat, Quique; Manaca, Maria Nélia; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Dubois, Marie-Claude; Loucq, Christian; Ballou, W. Ripley; Cohen, Joe; Alonso, Pedro L. // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: The RTS,S/AS02D vaccine has been shown to have a promising safety profile, to be immunogenic and to confer protection against malaria in children and infants. Methods and Findings: We did a randomized, controlled, phase I/IIb trial of RTS,S/AS02D given at 10, 14 and 18 weeks of age...

  • How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Sutherland, Colin J.; Drakeley, Christopher J.; Schellenberg, David // Malaria Journal;2007, Vol. 6, p161 

    The development of acquired protective immunity to Plasmodium falciparum infection in young African children is considered in the context of three current strategies for malaria prevention: insecticide-impregnated bed nets or curtains, anti-sporozoite vaccines and intermittent preventive...

  • VACUNA CONTRA LA MALARIA: PROGRESOS HASTA LA FECHA. Rabinovich, Regina // Vacunas: Prevención de enfermedades y protección de la salud;2004, p226 

    The article presents information on the progress made on the development of malaria vaccines. Even if malaria affects so many people, there is no malaria vaccine today. Malaria is a vector-borne infectious disease prevalent in tropical and subtropical regions. It is produced mainly by Plasmodium...

  • Pre-erythrocytic malaria vaccines: towards greater efficacy. Hill, Adrian V. S. // Nature Reviews Immunology;Jan2006, Vol. 6 Issue 1, p21 

    The complex life cycle of the malaria parasite Plasmodium falciparum provides many options for vaccine design. Several new types of vaccine are now being evaluated in clinical trials. Recently, two vaccine candidates that target the pre-erythrocytic stages of the malaria life cycle — a...

  • Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites. Hoffman, Stephen L.; Goh, Lucy M.L.; Luke, Thomas C.; Schneider, Imogene; Le, Thong P.; Doolan, Denise L.; Sacci, John; de la Vega, Patricia; Dowler, Megan; Paul, Chris; Gordon, Daniel M.; Stoute, Jose A.; Church, L.W. Preston; Sedegah, Martha; Heppner, D. Gray; Ballou, W.Ripley; Richie, Thomas L. // Journal of Infectious Diseases;4/15/2002, Vol. 185 Issue 8, p1155 

    During 1989-1999, 11 volunteers were immunized by the bites of 1001-2927 irradiated mosquitoes harboring infectious sporozoites of Plasmodium falciparum (Pf) strain NF54 or clone 3D7/NF54. Ten volunteers were first challenged by the bites of Pf-infected mosquitoes 2-9 weeks after the last...

  • Malaria: New target for vaccine development. Cully, Megan // Nature Reviews Drug Discovery;Aug2014, Vol. 13 Issue 8, p576 

    The article focuses on the identification of a protein involved in parasite egress, Plasmodium falciparum schizont egress antigen-1 (PfSEA-1), as an antigen in antimalarial vaccines.

  • Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage. Pollock, Tzvi; Leitao, Ricardo; Galan-Rodriguez, Cristina; Wong, Kurt A.; Rodriguez, Ana // Malaria Journal;2011, Vol. 10 Issue 1, p97 

    Background: Human populations that are naturally subjected to Plasmodium infection do not acquire complete protection against the liver stage of this parasite despite prolonged and frequent exposure. However, sterile immunity against Plasmodium liver stage can be achieved after repeated exposure...

  • A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19 kDa. Takala, Shannon L.; Smith, David L.; Stine, O. Colin; Coulibaly, Drissa; Thera, Mahamadou A.; Doumbo, Ogobara K.; Plowe, Christopher V. // Malaria Journal;2006, Vol. 5, p1 

    Background: Malaria vaccine efficacy may be compromised if the frequency of non-target alleles increases following vaccination with a genetically polymorphic target. Methods are needed to monitor genetic diversity in polymorphic vaccine antigens, but determining which genetic variants of such...

  • An individual-based model of Plasmodium falciparum malaria transmission on the coast of Kenya. Gu, Weidong; Killeen, Gerry F.; Mbogo, Charles M.; Regens, James L.; Githure, John I.; Beier, John C. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jan2003, Vol. 97 Issue 1, p43 

    Individual-based models provide powerful tools to model complex interactions characterized by individual variability. This paper presents an object-oriented design for individual-based modelling of Plasmodium falciparum malaria transmission. Two kinds of objects, human and mosquito, that exhibit...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics